Clinical Trial Navigator

Model: meta-llama/llama-3.3-70b-instruct
Status: Completed
Cost: $0.046
Tokens: 155,190
Started: 2026-01-05 14:35

Executive Summary

✅ VERDICT: GO BUILD

Strong viability across all dimensions with clear path to market.

One-Line Summary

Clinical Trial Navigator is a mobile-first platform that simplifies the process of finding and tracking clinical trials for patients and caregivers, leveraging AI to match users with relevant trials and provide plain language explanations of complex eligibility criteria.

Core Problem Solved

The current process of finding clinical trials is overwhelming for patients and caregivers, with over 450,000 studies listed on ClinicalTrials.gov and complex eligibility criteria that are difficult to understand. This results in missed opportunities for potentially life-changing treatments.

Primary Audience

The primary audience is patients with chronic or serious conditions, such as cancer, rare diseases, and autoimmune disorders, who are actively seeking treatment options beyond standard care. The secondary audience is caregivers researching on behalf of family members.

Market Size Breakdown

TAM (Total Addressable Market): $2B+ clinical trial recruitment market
SAM (Serviceable Addressable Market): $500M patient-centric clinical trial recruitment
SOM (Serviceable Obtainable Market): $50M first-year revenue potential with 10% market share

Market Timing ("Why Now?")

The market is ripe for a patient-centric clinical trial platform due to the growing demand for personalized medicine, advancements in AI and natural language processing, and the increasing importance of patient engagement in clinical research.

Competitive Positioning Matrix

ClinicalTrials.gov

Official source, poor UX, no personalization

Clinical Trial Navigator

Patient-centric, AI-powered matching, plain language explanations

Financial Snapshot

  • Estimated MVP Development Cost: $200,000 - $300,000
  • Revenue Model: Freemium SaaS with premium features and B2B partnerships
  • Break-Even Timeline: 6-12 months after launch

Top 3 Highlights

Market Opportunity

$2B+ clinical trial recruitment market with growing demand for patient-centric solutions

Unique Value Proposition

AI-powered matching and plain language explanations for clinical trials

Competitive Advantage

Patient-centric approach with AI-powered matching and plain language explanations

Overall Viability Scores

Market Validation:

8/10

Technical Feasibility:

9/10

Competitive Advantage:

8.5/10

Business Viability:

8/10

Execution Clarity:

8.5/10

Verdict

Based on the composite viability score, the verdict is ✅ GO BUILD. The market opportunity is significant, and the unique value proposition and competitive advantage are strong.

Critical Success Factors

  • Accurate AI-powered matching
  • Clear and concise plain language explanations
  • Strong user engagement and retention
  • Effective B2B partnerships and revenue growth
  • Continuous improvement and iteration

Key Risks & Mitigations

Risk: Medical advice liability

Mitigation: Clear disclaimers, no treatment recommendations, encourage physician consultation

Risk: Data accuracy

Mitigation: Regular sync with official sources, user feedback loop

Success Metrics (First 6 Months)

  • Monthly active users: 10,000+
  • Trial matches per user: 5+
  • Click-through to trial coordinator contact: 20%+

Recommended Next Steps

  1. Conduct market research and user interviews to validate assumptions
  2. Develop a minimum viable product (MVP) with core features
  3. Establish B2B partnerships with pharmaceutical companies and research institutions
  4. Launch a targeted marketing campaign to acquire users
  5. Continuously iterate and improve the platform based on user feedback